Telix Pharmaceuticals Limited Share Price
NASDAQ: TLXTelix Pharmaceuticals Limited Stock Performance
Telix Pharmaceuticals Limited Share Price Today
As of 29 October 2026, Telix Pharmaceuticals Limited's share price is $9.53. The stock opened at $9.54, compared to its previous close of $9.26. During today's trading session, Telix Pharmaceuticals Limited's share price traded between $9.52 and $9.56, with an average price of $9.54. Over the past 52 weeks, the stock has recorded a high of $13.09 and a low of $6.28. In terms of performance, Telix Pharmaceuticals Limited's share price has declined by 13.28% over the last six months and is down 10.35% on a year-on-year basis.
Telix Pharmaceuticals Limited Share Price Chart
About Telix Pharmaceuticals Limited
Telix is a developer of radiopharmaceuticals. Radiopharmaceuticals are specialized drugs containing radioactive isotopes, which are used in both diagnosing and treating cancer. At low doses, these drugs bind to a specific cancer cell and can be visualized through PET imaging. With high doses, they can deliver targeted treatment. Telix has a pipeline of both diagnostics and therapeutics in development. Its pipeline is focused on urologic oncology (prostate, kidney and bladder), neuro-oncology (glioma), musculoskeletal oncology and hematology. Currently, most of the firm's revenue comes from its Illuccix prostate cancer imaging/diagnostic agent.
Telix Pharmaceuticals Limited Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $10.90 | $9.53 | -12.85% |
Sep 2026 | $10.92 | $10.94 | -3.70% |
Aug 2026 | $9.93 | $11.36 | +14.47% |
Jul 2026 | $11.76 | $9.92 | -14.04% |
Jun 2026 | $9.38 | $11.54 | +22.38% |
May 2026 | $11.18 | $9.43 | -14.19% |
Apr 2026 | $9.43 | $10.99 | +14.78% |
Mar 2026 | $6.92 | $9.57 | +32.25% |
Feb 2026 | $7.42 | $7.24 | -1.03% |
Jan 2026 | $7.62 | $7.32 | -2.34% |
Dec 2025 | $9.82 | $7.49 | -24.91% |
Nov 2025 | $10.52 | $9.97 | -6.16% |